Metastatic Gastrointestinal Stromal Tumor (GIST) Active Not Recruiting Phase 2 Trials for Rogaratinib (DB15078)

Also known as: Metastatic Gastrointestinal Stromal Tumor / Metastatic Gastrointestinal Stromal Tumors (GIST)

IndicationStatusPhase
DBCOND0141952 (Metastatic Gastrointestinal Stromal Tumor (GIST))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04595747Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)Treatment